• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Investing Jefferies analyst reveals his top two biotech stocks for 2023
Investing

Jefferies analyst reveals his top two biotech stocks for 2023

by December 28, 2022
by December 28, 2022 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

Moderna Inc (NASDAQ: MRNA) has tanked nearly 15% in recent days but a Jefferies analyst dubs it one of his best ideas for 2023.

Moderna stock could climb another 50%

Earlier in December, the biotech company said its candidate vaccine for skin cancer showed encouraging results in a Phase II study (read more). That’s what Michael Yee is most bullish about.  

I think that story will continue to unfold in 2023. Partner Merck is very bullish on this programme and opening up a lot of studies, including in lung cancer. So, it’s the first chapter and an important development.

The Nasdaq-listed firm will soon report Phase III data for its experimental RSV vaccine as well. Yee sees that as another reason to buy Moderna stock.  

He now sees upside in “MRNA” to $275 – up another 50% from here.

Yee is also bullish on the Amgen stock

A legacy name within “biotech” that pops out to Jefferies’ Michael Yee is Amgen Inc (NASDAQ: AMGN) that’s already up more than 15% for the year. Explaining why on CNBC’s “Closing Bell”, he said:

A more defensive large biotech company like Amgen is quite attractive in this difficult environment. [Also] in an offensive position where a renaissance of pipeline that has been going under appreciated.

The analyst is also constructive on its obesity drug currently named “AMG133” that was recently shown to have promising durability. Yee values the market for obesity drug at $20 billion to $50 billion.  

Earlier this month, Amgen Inc revealed plans of buying Horizon Therapeutics Plc for nearly $28 billion.

The post Jefferies analyst reveals his top two biotech stocks for 2023 appeared first on Invezz.

You Might Also Like
  • Mastering the Art of Options Trading: Tips for Small Accounts
  • 2 takeaways from the last NFP report of 2022
  • Aptos startup Blocto eyes the next billion Web3 users via chain-agnostic wallet
  • Zscaler stock opened 10% down on Friday: how come?
Share
0
FacebookTwitterPinterestWhatsapp

previous post
This is what you should expect from U.S. stocks in Q1 of 2023
next post
Galaxy to acquire Helios Bitcoin mining facility from Argo Blockchain

You may also like

Options Spreads: Put & Call Combination Strategies

April 19, 2023

Jim Cramer on the Airbnb stock: ‘I would own it’

December 23, 2022

Take cover as M2 growth hits zero and monetary lags...

December 30, 2022

Tesla stock is still ‘egregiously overvalued’: Analyst

December 9, 2022

Pinterest stock price forecast: Piper Sandler sees a 25% upside

December 13, 2022

Please Follow Me Inside The Insiders

March 6, 2024

How Investment Trading Can Help Grow Your Business

January 16, 2023

It’s time to move to the sidelines on Salesforce stock:...

January 11, 2023

Bruce Kovner’s 4 trading principles that made him one of...

November 29, 2022

Best Options Strategies for Trading Earnings

April 14, 2023

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout, pulls outlook

      May 8, 2025
    • Don’t Buy Robinhood Stock… Until You See This Chart Setup

      May 8, 2025
    • UnitedHealthcare sued by shareholders over reaction to CEO’s killing

      May 8, 2025
    • The Unpredictable Stock Market: How to Make Sense of It

      May 8, 2025
    • AMD CEO calls China a ‘large opportunity’ and warns against strict U.S. chip controls

      May 7, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,632 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,339 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,320 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,302 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,186 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,066)
    • Investing (538)
    • Stock (2,530)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout,...

      May 8, 2025
    • Don’t Buy Robinhood Stock… Until You See This Chart Setup

      May 8, 2025
    • UnitedHealthcare sued by shareholders over reaction to CEO’s killing

      May 8, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,066)
    • Investing (538)
    • Stock (2,530)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Coinbase, Galaxy Digital shares rise sharply...

    December 29, 2022

    Morgan Stanley recommends avoiding Airbnb stock...

    December 7, 2022

    Decred launches new social media platform...

    December 16, 2022
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here